Deltex Medical Group PLC (LSE:DEMG) - Share price - Overview


Stock Report

Deltex Medical Group PLC DEMG

Last Price
GBX1.30

Day Change
-0.05|-3.70%

As of 20/03/2019
12:49:33 GMT | GBX
Minimum 15 Minutes Delay.

Last Close1.35p
Day Range1.20 - 1.38
Mkt Cap6.52Mil
52-Wk Range0.72 - 1.75
Yield %-
ISINGB0059337583
Volume417,231
P/E-1.86
P/S0.01
P/CF-0.04

Share Price

Total Returns 20/03/2019

 Chg (%)  
More ...
Deltex Medical Group PLC13.04 
FTSE 100 TR GBP1.58
 
Financials
201520162017
More ...
Income Statement
Turnover6.416.335.87
Operating Profit-3.33-2.37-1.94
Net Profit-3.46-2.38-2.00
Reported EPS-1.60-0.90-0.70
Balance Sheet
Current Assets4.133.953.12
Non Current Assets2.582.832.76
Total Assets6.716.785.88
Current Liabilities4.633.273.46
Total Liabilities---
Total Equity1.922.421.30
Cash Flow
Operating Cash Flow-1.84-1.98-1.04
Net Change in Cash-2.36-0.05-0.35
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
05/02/2019PurchaseMr. Nigel John Keen1.138,695,65297,826.00
24/08/2018PurchaseMr. Nigel John Keen0.902,000,00018,000.00
23/08/2018Transfer outMr. Nigel John Keen0.006,000,0000.00
22/08/2018PurchaseMr. Nigel John Keen0.901,000,0009,000.00

Company Profile

Deltex Medical Group PLC develops, designs, manufactures and markets medical equipment that deploys low-frequency ultrasound to visualise and measure blood flow in the central circulation. The company's segments are Probes and Other.

Sector

Medical Devices

Index

FTSE AIM All-Share

Next Event 09/05/2019

Final Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-80.78
Op Mrgn-0.33
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive DirectorProf Sir Duncan Kirkbride Nichol CBE
Non-Executive Director, ChairmanMr. Nigel John Keen
Non-Executive DirectorMr. Julian Cazalet
Non-Executive DirectorMr. Mark Alexander Wippell
Non-Executive DirectorMr. Christopher Michael Jones
Executive Director, Group Finance Director and Company SecretaryMr. Jonathan David Shaw
Executive Director, Chief Executive OfficerMr. Andrew Jonathan Mears
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.